Litcius/Paper detail

Blumgart Anastomosis After Pancreaticoduodenectomy. A Comprehensive Systematic Review, Meta‐Analysis, and Meta‐Regression

Claudio Ricci, Carlo Ingaldi, Laura Alberici, Nico Pagano, Cristina Mosconi, Giovanni Marasco, Francesco Minni, Riccardo Casadei

2021World Journal of Surgery21 citationsDOIOpen Access PDF

Abstract

BACKGROUND: The superiority of Blumgart anastomosis (BA) over non-BA duct to mucosa (non-BA DtoM) still remains under debate. METHODS: We performed a systematic search of studies comparing BA to non-BA DtoM. The primary endpoint was CR-POPF. Postoperative morbidity and mortality, post-pancreatectomy hemorrhage (PPH), delayed gastric emptying (DGE), reoperation rate, and length of stay (LOS) were evaluated as secondary endpoints. The meta-analysis was carried out using random effect. The results were reported as odds ratio (OR), risk difference (RD), weighted mean difference (WMD), and number needed to treat (NNT). RESULTS: Twelve papers involving 2368 patients: 1075 BA and 1193 non-BA DtoM were included. Regarding the primary endpoint, BA was superior to non-BA DtoM (RD = 0.10; 95% CI: -0.16 to -0.04; NNT = 9). The multivariate ORs' meta-analysis confirmed BA's protective role (OR 0.26; 95% CI: 0.09 to 0.79). BA was superior to DtoM regarding overall morbidity (RD = -0.10; 95% CI: -0.18 to -0.02; NNT = 25), PPH (RD = -0.03; 95% CI -0.06 to -0.01; NNT = 33), and LOS (- 4.2 days; -7.1 to -1.2 95% CI). CONCLUSION: BA seems to be superior to non-BA DtoM in avoiding CR-POPF.

Topics & Concepts

MedicineOdds ratioAbdominal surgeryClinical endpointConfidence intervalInternal medicineNumber needed to treatGastroenterologyVascular surgerySurgeryCardiothoracic surgeryCardiac surgeryRelative riskRandomized controlled trialPancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct DisordersGastric Cancer Management and Outcomes